Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
Gopalan
Priya K
PK
Department of Medicine, Washington University School of Medicine, Mailstop 8056, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
Clohisy
John C
JC
Cashen
Amanda F
AF
Eby
Charles S
CS
D000368:Aged; D019644:Arthroplasty, Replacement, Hip; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D013293:Enterococcus faecalis; D005167:Factor VII / Q000008:administration & dosage / Q000627:therapeutic use*; D005168:Factor VII Deficiency / Q000151:congenital / Q000188:drug therapy* / Q000453:epidemiology*; D015942:Factor VIIa; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D008297:Male; D015207:Osteoarthritis, Hip / Q000453:epidemiology* / Q000601:surgery; D016459:Prosthesis-Related Infections / Q000453:epidemiology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa